Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Analysis).

Authors:
Hill AR; Bedi P; Cartlidge MK; Turnbull K; Donaldson S and 6 more

Journal:
Lung

Publication Year: 2023

DOI:
10.1007/s00408-023-00601-1

PMCID:
PMC9968257

PMID:
36746812

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Lung

Abbreviation: Lung

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Elevated Eosinophil Counts in Acute Exacerbations of Bronchiectasis: Unveiling a Distinct Clinical …
Chen W; Ran S; Li C and 4 more (2024) - Transparency Score: 3/6
Analytic Morphomics in Myositis-Related Interstitial Lung Disease.
O'Mahony AT; Henry PJ; Coghlan P and 8 more (2023) - Transparency Score: 3/6
Chronic Cough as a Genetic Neurological Disorder? Insights from Cerebellar Ataxia with Neuropathy a…
Turner RD; Hirons B; Cortese A and 1 more (2023) - Transparency Score: 3/6
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled P…
Dicpinigaitis PV; Morice AH; Smith JA and 11 more (2023) - Transparency Score: 4/6
Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with …
Papi A; Stapleton RD; Shore PM and 4 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThere are no conflicts of interest from the above authors. Conflict of interest There are no conflicts of interest from the above authors."

Evidence found in paper:

"Funding None."

Evidence found in paper:

"Conclusion: The clinical response to treatment was similar but patients with coexisting asthma were at increased risk of early relapse within 14 days of stopping intravenous antibiotic therapy. Clinical Trial Registration: NCT02047773."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025